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ABSTRACT
Background and the purpose of the study: The poor bioavailability and therapeutic response 
exhibited by the conventional ophthalmic solutions due to precorneal elimination of the drug may 
be overcome by the use of mucoadhesive in situ gel forming systems that are instilled as drops 
into the eye and undergo a sol-gel transition in the cul-de-sac and have good mucoadhesion with 
ocular mucus layers. The objective of this study was to formulate ophthalmic mucoadhesive 
system  of  gatifloxacin  (GTN)  and  to  evaluate  its  in  vitro  antibacterial  potential  against, 
Staphylococcus aureus and Escherichia coli. 
Methods: Mucoadhesive systems were prepared using gellan combined with sodium 
carboxymethylcellulose (NaCMC) or sodium alginate to enhance the gel bioadhesion properties. 
The prepared formulations were evaluated for their gelation, and rheological behaviors, 
mucoadhesion force, in vitro drug release, and antibacterial activity. 
Results:  All formulations in non-physiological or physiological conditions showed 
pseudoplastic behaviors. Increase in the concentration of mucoadhesive agent enhanced the 
mucoadhesive force significantly. In vitro release of gatifloxacin from the mucoadhesive 
system in simulated tear fluid (STF, pH of 7.4) was influenced significantly by the properties 
and concentration of gellan, sodium carboxymethyl cellulose and sodium alginate. Significant 
reduction  in  the  total  bacterial  count  was  observed  between  drug  solution  (control)  and 
mucoadhesive batches against both tested organisms. 
Major conclusion: The developed mucoadhesive system is a viable alternative to conventional 
eye drops of GTN due to its ability to enhance bioavailability through its longer precorneal 
residence time and ability to sustain the release of the drug.
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INTRODUCTION
 Topical delivery of eye drops is the most common 
practice of drug treatment in ocular diseases. The 
sites of action of most of the ophthalmic drugs are 
located in the inner eye. Although, external eye 
structures are readily accessible, the biological 
barriers, mainly the corneal epithelium, limit ocular 
drug absorption (1, 2).
Ocular  therapy  would  be  significantly  improved 
if the precorneal residence time of drugs could be 
increased.  Several  new  preparations  have  been 
developed for ophthalmic use, not only to prolong 
the contact time of the vehicle on the ocular 
surface, but also to slow down drug elimination 
(3, 4). Successful results have been obtained with 
inserts (4) and collagen shields (5). However, these 
preparations also have some disadvantages, such as 
poor compliance, especially by elderly people, and 
loss of the device in some patients without noticing 
it. From the view point of acceptability many patients 
prefer, a liquid dosage form.
Mucus is a viscous and heterogeneous biological 
product  that  coats  many  epithelial  surfaces  (6). 
Mucus-secreting cells are widely spread in different 
locations in the body, including the nasal, ocular and 
buccal area and the gastrointestinal, reproductive 
and respiratory tracts.
Mucoadhesive drug delivery systems utilize 
bioadhesive property of certain water-soluble 
polymers that become adhesive to mucous 
membranes on hydration (7) and hence can be used 
for targeting a drug to a particular region of the body 
for an extended period of time (8). 
The idea of mucoadhesives was derived from the 
need to localize drugs at a certain site in the body. The 
extent of drug absorption is limited by the residence 
time of the drug at the absorption site. Particularly, in 
ocular drug delivery, less than 2 min is available for 238 ?
purchased  from  Merck  (Mumbai,  India).  Sodium 
bicarbonate was purchased from SD fine chemical 
Ltd.  (Mumbai,  India). All  other  reagents  were  of 
analytical grade.
Preparation of formulations
Gellan alone and in combination with sodium 
alginate and sodium carboxymethylcellulose (Table 
1)  was  dissolved  in  hot  acetate  buffer  of  pH  5.0 
(70°C, prepared in fresh water for injection under 
laminar flow) by continuous stirring at 40°C. Then 
300mg of gatifloxacin was added to the polymeric 
solution and stirred until dissolved. Mannitol 
and benzalkonium chloride which were used as 
isotonicity agent and a preservative, respectively, 
were added later. The formulations were filled in 
sterile 100 ml amber coloured bottles, capped with 
rubber closures and sealed with aluminum caps. The 
formulations,  in  their  final  pack  were  terminally 
sterilized by autoclaving at 121°C and 15 p.s.i. for 
20 min. The sterilized formulations were stored in 
refrigerator (4-8°C) until further use.
Evaluation of the formulations
Drug content uniformity
The  bottle  (n  =  3)  containing  the  preparations 
was  shaken  for  2-3  min  and  by  a  micropipette                     
100 µl of the preparation was transferred aseptically 
to  sterile  25  ml  volumetric  flasks  and  the  final 
volume  was  made  up  with  Simulated  Tear  Fluid 
(Sodium  chloride,  0.67  g,  Sodium  bicarbonate, 
0.20 g, Calcium chloride (2H2O), 0.008 g, Distilled 
water, q.s. 100 ml). The concentration of GTN was 
determined at 287 nm (Shimadzu, UV-1601, Japan).
Gelation studies
The gelation studies were carried out in gelation 
cells, fabricated locally using Teflon. The cells were 
cylindrical reservoirs capable of holding 3 ml of the 
gelation  solution  (STF).  Within  the  cells  located 
at the bottom was a 250 µl transparent plastic cup 
to hold the gel sample in place after its formation. 
Carefully 100 µl of the preparation was placed into 
the cavity of the cup using a micropipette and 2 ml 
of the gelation solution was added slowly. Gelation 
was deducted by visual examination.
Rheological studies
Viscosity  evaluations  of  the  prepared  GTN 
formulations were carried out using Brookfiled DV-
111+ Rheometer with spindle LV-3. The viscosity 
of the formulations, either in non-physiological (pH 
of 5.0) or Physiological conditions (pH of 7.2) was 
determined  using  a  50  ml  aliquot  of  the  sample. 
Viscosity  of  samples  were  measured  at  different 
angular velocities from 10 to 100 rpm with an equal 
wait for 3 min in each rpm. The angular velocity was 
reversed (100 to 10 rpm). The average of the two 
readings was used to calculate the viscosity.
drug absorption after instillation of a drug solution 
into the eye and since the drug is removed rapidly 
by solution drainage hence the ability to extend 
contact time of an ocular drug delivery system in 
front of the eye would undoubtedly improve drug 
bioavailability.
Gatifloxacin,  a  fourth  generation  fluoroquinolone  is 
used to treat bacterial conjunctivitis (9). It is the drug 
of choice in the treatment of bacterial infections and 
available as eye drops and eye ointments in the market. 
Newer formulation components are being explored 
to develop a comprehensive and controlled release 
strategy. Utilization of the principle of sustained release 
as embodied by mucoadheisve systems therefore offers 
an attractive alternative approach to the difficulties of 
prolonging pre-corneal drug residence time.
Sodium  CMC  and  sodium  alginate  were  selected 
as mucoadhesive polymers due to their better 
mucoadhesive capacity compared to other 
mucoadhesive  polymers  like  poly  (acrylic  acid) 
(PAA)  and  polycarbophils.  PAA  adhesion  is  very 
sensitive to the presence of ions and the shielding of 
the carboxyl group by cations present in the tear fluid 
diminish the interaction of PAA with the functional 
group  on  mucin  (10).  Polycarbophil  shows  the 
maximum adhesion strength at pH of 3, decreasing 
gradually by increasing pH, towards 5, above which 
it does not show any mucoadhesivity.
A combination of gellan with sodium alginate or 
sodium CMC would be very promising for ocular 
administration as a mucoadhesive system. The 
result could be a prolonging of the contact time. In 
fact, mucoadhesive in situ gelling ocular inserts of 
gatifloxacin  (11),  have  been  already  studied.  For 
better patient acceptability, a liquid dosage form 
that can sustain drug release and remain in contact 
with the cornea for extended periods of time is 
an ideal option. Our objective was to develop a 
mucoadhesive system of gatifloxacin using gellan 
alone and in combination with sodium alginate 
or sodium carboxymethylcellulose which would 
undergo gelation when instilled into the cul-de-sac 
of the eye and provide prolonged retention on the 
external ocular surface. 
MATERIAL AND METHODS
Gatifloxacin  (GTN)  and  Gellan  gum  were  the 
kind gifts by Burgeon Pharmaceutical Pvt. Ltd., 
(Kancheepuram, India) and ISP (Hong Kong Ltd., 
Hyderabad,  India),  respectively.  Sodium  alginate 
and sodium carboxymethyl cellulose were kind 
gifts of Dr.Reddy’s laboratory (Hyderabad, India). 
Benzalkonium chloride was purchased from 
RFCL Ltd. (New Delhi, India). Mucin type II and 
Cellulose membrane were purchased from Sigma-
Aldrich chemicals pvt. Ltd., New Delhi. Mannitol 
was purchased from Sisco Research Lab. (Mumbai, 
India). Sodium Chloride, Sodium acetate, Calcium 
chloride  (2H2O)  and  Glacial  acetic  acid  were 
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Mucoadhesive evaluation 
A simple viscometric method was used to quantify 
mucin-polymer  mucoadhesive  strength  (12). 
Viscosities  of  15%  (w/v)  porcine  gastric  mucin 
dispersions in STF were measured with a Brookfield 
viscometer  in  the  absence  (ηm)  or  presence  (ηt) 
of different formulations at 37°C and a shear rate 
of  100  rpm.  Viscometric  measurements  were 
performed after exactly 3 min of applying the shear 
force for homogeneous distribution throughout the 
sample. Viscosity components of mucoadhesion (ηb) 
were calculated from the equation, ηt = η m + η p + 
ηb, where ηp is the viscosity of corresponding pure 
polymer solution. The force of mucoadhesion (F) 
was calculated from the equation, F = ηb.σ, where σ 
is the rate of shear/sec.
In vitro release studies
The in vitro release of GTN from the formulation 
was studied through cellulose membrane using 
modified  apparatus  (13).  The  freshly  prepared 
STF  was  used  as  dissolution  medium.  Cellulose 
membrane  (molecular  weight  cut  off  12,000  D, 
Sigma-Aldrich Chemicals, India), previously soaked 
overnight in the dissolution medium was tied to one 
end of a specifically designed glass cylinder (open 
at both ends). One ml of the formulation (equivalent 
to 3 mg of GTN) was mixed with 3 ml of STF and 
placed into this assembly. The cylinder was attached 
to a stand and suspended in 50 ml of dissolution 
medium maintained at 37 ± 1°C and the membrane 
just touching the receptor medium surface. The 
dissolution medium (STF) was stirred with a star 
headed magnetic bead at 50 rpm. Aliquots of 5 ml 
volume were withdrawn at regular time intervals and 
replaced with an equal volume of the pre-warmed 
medium. The samples were analyzed for GTN 
content  at  287  nm  using  UV  spectrophotometer 
(Shimadzu-1601, Japan). The in vitro release was 
studied for the control (without polymer) in order 
to  compare  the  release  profile  with  the  prepared 
mucoadhesive system of gatifloxacin. 
Mechanism of drug Release
In order to elucidate kinetics of the drug release, data 
were analyzed using: zero-order equation, Q = Q0 + Kt; 
first-order equation, Q = Q0 e−kt (14, 15) and Higuchi’s 
square root model, Q = K√t  (16). Where, Q is the amount 
of drug released in time “t”. Q0 is the initial dose, K is 
the release constant of the respective equations, and t 
is the release time. In order to find out the drug release 
mechanism from the mucoadhesive systems, the data 
were fitted to Korsmeyer–Peppas’ power equation (17, 
18): Mt/M∞ = Ktn where, Mt /M∞ is the fraction of drug 
released in time “t,” K is a constant incorporating 
structural and geometrical characteristics of the drug/
polymer system, and n is the release exponent, which 
is indicative of the drug-release mechanism. When n is 
equal to 0.5, the drug is released from the polymer with 
Fickian diffusion mechanism. If 0.5<n<1 , it indicates 
anomalous or non-Fickian release, whereas if n = 1, 
it indicates zero-order release.
Antimicrobial efficacy studies
Determination of minimum inhibitory concentration 
(MIC)
The  MIC  is  defined  as  the  lowest  concentration 
of the antibiotic that inhibits all visible growth 
and was determined by serial dilution method 
(19).  Staphylococcus aureus (ATCC  25923)  and 
Gatifloxacin mucoadhesive gellan system
S. No Batch 
code
Drug
(% w/v)
Gellan
(% w/v)
Sodium 
alginate
(% w/v)
NaCMC
(% w/v)
Drug 
Content
(% ± S. D.)a
Gelling
Capacity 
in STFa
Mucoadhesion
Force
(dyne/cm2)a
1 Control 0.3 - - - 99.58± 1.05 - -
2 GG1 0.3 0.015 - - 99.42 ± 0.86 + 6.18±1.61
3 GG2 0.3 0.03 - - 98.54 ± 1.04 ++ 13.36±1.39
4 GG3 0.3 0.03 - 0.1 99.48±1.2 +++ 30.56±2.28
5 GG4 0.3 0.03 - 0.25 101.1±0.95 +++ 44.26±3.75
6 GG5 0.3 0.03 - 0.5 98.87±0.52 +++ 66.13±2.46
7 GG6 0.3 0.045 - - 99.24 ± 0.41 +++ 19.54±1.73
8 GG7 0.3 0.06 - - 99.18 ± 0.64 +++ 22.04±2.84
9 GM1 0.3 0.03 0.4 - 98.85±0.95 +++ 29.39±1.51
10 GM2 0.3 0.03 0.6 - 99.45±0.76 +++ 40.58±3.34
11 GM3 0.3 0.03 0.8 - 100.06±0.82 +++ 60.45±3.43
All formulation containing 5% Mannitol and 0.02% benzalkonium chloride were used as isotonic agent and preservative, respectively.
+ - Gels after few minutes; ++ - Gels immediately but remains for a few hrs (less stiffer); 
+++ - Immediate gelation and remains for extended periods and formed gels are stiffer.
a Values reported as mean ± SD (n = 3)
Table1. Components and evaluation of mucoadhesive system of gatifloxacin.
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at the bottom was a 250 µl transparent plastic cup 
to hold the gel sample in place after its formation. 
Carefully 100 µl of the preparation was placed into 
the cavity of the cup using a micropipette and 2 ml 
of the gelation solution was added slowly. Gelation 
was deducted by visual examination.
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Viscosity  evaluations  of  the  prepared  GTN 
formulations were carried out using Brookfiled DV-
111+ Rheometer with spindle LV-3. The viscosity 
of the formulations, either in non-physiological (pH 
of 5.0) or Physiological conditions (pH of 7.2) was 
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by solution drainage hence the ability to extend 
contact time of an ocular drug delivery system in 
front of the eye would undoubtedly improve drug 
bioavailability.
Gatifloxacin,  a  fourth  generation  fluoroquinolone  is 
used to treat bacterial conjunctivitis (9). It is the drug 
of choice in the treatment of bacterial infections and 
available as eye drops and eye ointments in the market. 
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to develop a comprehensive and controlled release 
strategy. Utilization of the principle of sustained release 
as embodied by mucoadheisve systems therefore offers 
an attractive alternative approach to the difficulties of 
prolonging pre-corneal drug residence time.
Sodium  CMC  and  sodium  alginate  were  selected 
as mucoadhesive polymers due to their better 
mucoadhesive capacity compared to other 
mucoadhesive  polymers  like  poly  (acrylic  acid) 
(PAA)  and  polycarbophils.  PAA  adhesion  is  very 
sensitive to the presence of ions and the shielding of 
the carboxyl group by cations present in the tear fluid 
diminish the interaction of PAA with the functional 
group  on  mucin  (10).  Polycarbophil  shows  the 
maximum adhesion strength at pH of 3, decreasing 
gradually by increasing pH, towards 5, above which 
it does not show any mucoadhesivity.
A combination of gellan with sodium alginate or 
sodium CMC would be very promising for ocular 
administration as a mucoadhesive system. The 
result could be a prolonging of the contact time. In 
fact, mucoadhesive in situ gelling ocular inserts of 
gatifloxacin  (11),  have  been  already  studied.  For 
better patient acceptability, a liquid dosage form 
that can sustain drug release and remain in contact 
with the cornea for extended periods of time is 
an ideal option. Our objective was to develop a 
mucoadhesive system of gatifloxacin using gellan 
alone and in combination with sodium alginate 
or sodium carboxymethylcellulose which would 
undergo gelation when instilled into the cul-de-sac 
of the eye and provide prolonged retention on the 
external ocular surface. 
MATERIAL AND METHODS
Gatifloxacin  (GTN)  and  Gellan  gum  were  the 
kind gifts by Burgeon Pharmaceutical Pvt. Ltd., 
(Kancheepuram, India) and ISP (Hong Kong Ltd., 
Hyderabad,  India),  respectively.  Sodium  alginate 
and sodium carboxymethyl cellulose were kind 
gifts of Dr.Reddy’s laboratory (Hyderabad, India). 
Benzalkonium chloride was purchased from 
RFCL Ltd. (New Delhi, India). Mucin type II and 
Cellulose membrane were purchased from Sigma-
Aldrich chemicals pvt. Ltd., New Delhi. Mannitol 
was purchased from Sisco Research Lab. (Mumbai, 
India). Sodium Chloride, Sodium acetate, Calcium 
chloride  (2H2O)  and  Glacial  acetic  acid  were 
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Escherichia coli (ATCC  25922)  were  used  as 
gram-positive and gram-negative micro organisms, 
respectively.
The stock solution of gatifloxacin in both standard 
and test were prepared in the concentration of 3 mg/
ml in acetate buffer (pH of 5.0). Fifteen sterile test 
tubes were arranged in a rack and numbered from 
1 to 15. From the stock solution serial dilution was 
made using Lubria (LB) broth to give concentrations 
of 76.5 μg/ml to 0.02 μg/ml placed in 1st tube to 13th 
tube. One tube was considered as the positive control 
and another tube as the negative control. Following 
subcultures from frozen stock, 10 μl broth of the 
standard S.aureus and E.coli containing 1x106 CFU/
ml strains were inoculated in all test tubes except 
in negative control and incubated at 37°C for 24 
hrs to observe growth. The tubes were observed for 
inhibition of growth and MIC was determined.
In vitro antibacterial activity
The in vitro antimicrobial sensitivity of the 
formulation was examined in vitro by a standard 
procedure (19). One milliliter of the sample (GG5) 
was mixed with 100 ml of STF solution for gelation. 
Then one milliliter of the above solution was added 
to a set of test tubes containing cultures of standard 
E.coli and S.aureus (1x106 CFU/ml) in LB broth. In 
another set of experiment drug solution equivalent 
to 30 µg was used. The test tubes were incubated at           
37 ± 0.2°C, with continuous shaking. At 1,2,3,4,5,6,7 
and 8 hrs time intervals, bacterial growth was 
determined  by  reading  optical  density  at  600  nm 
(OD  600).  Positive  and  negative  controls  were 
maintained throughout the study for comparison. 
The entire test was performed in triplicate and the 
values corresponded to average ± S.D.
Interaction studies
Interaction  studies  were  conducted  by  FT-IR  and 
DSC to investigate any interaction between drug and 
excipients.
IR Study
The drug or polymer or freeze dried formulations 
(GG5 and GM3) were mixed with solid potassium 
bromide (KBr). The mixture was then pressed into 
a very thin pellet. The pellets were placed in the 
holder directly in the IR laser beam. Spectra were 
recorded  using  Shimadzu  FTIR-8400s  loaded 
with IR solution version 1.2 software. IR spectra 
of drug and polymer physical mixture were 
compared with IR spectra of pure drug for any 
major interaction.
DSC Study
The samples (2.5 mg) were taken in the solid state in 
the pan and were compressed with a high-pressure 
press.  DSC  of  the  samples  were  recorded  using 
Modulated DSC systems (Q 1000 TA equipped with 
software Pyris 6.0). Thermal scanning was carried 
out at a rate of 10°C min-1 (from 0 to 300°C)) and 
nitrogen purge 35 ml/min.
RESULTS AND DISCUSSION
 
Preparation of Formulations
The compositions of the various batches of the GTN 
mucoadhesive system are shown in table 1. Initial 
experiments showed that increasing the concentration 
of gellan gum, in preparations containing only 
gellan,  beyond  0.06%  w/v  caused  gelation  upon 
cooling to 40°C (during stirring). The ionic content 
of acetate buffer of pH of 5.0 which was used as 
vehicle in this case, could have contributed to the 
gelation of gellan when used beyond 0.06%, so that 
beyond this concentration gellan could not be used, 
since it form gel during the preparation process itself. 
Therefore less than this concentration was used in 
this study. In the combination systems with sodium 
alginate or sodium CMC, the concentration of gellan 
was  kept  constant  at  0.03%. A  similar  result  for 
ciprofloxacin, from gellan-based formulations with 
an increase in polymer concentration, is reported 
(20). Sodium alginate and sodium CMC were used 
as mucoadhesive agents combined with gellan at the 
concentration of 0.2, 0.4, 0.6% w/v and 0.1, 0.25, 
and  0.5%  w/v,  respectively  provided  the  defined 
fluidity of the liquid formulation.
Evaluation of the formulations
The physico-chemical properties of the prepared 
gatifloxacin formulations are shown in table 1. The 
drug  content,  clarity  and  pH  of  the  formulations 
were found to be satisfactory and the formulations 
were liquid at both room temperature and when 
refrigerated. The two main pre-requisites of 
mucoadhesive systems are viscosity and gelling 
capacity (speed and extent of gelation). Moreover, 
a mucoadhesive system should preserve its integrity 
without dissolving or eroding for a prolonged period 
of time to facilitate sustained release of the drug 
to the ocular tissues. All the formulations showed 
instantaneous gelation when contacted with the 
gelation fluids (STF). However, the nature of the 
gel which was formed depended to the polymer 
concentration. In the case of gatifloxacin formulation 
batch GG1 showed the weakest gelation, due to the 
presence of minimal amount of gellan (0.015%). 
Rheological studies
The administration of an ophthalmic formulation 
should  not  influence  the  pseudoplastic  nature  of 
the  precorneal  film,  or  the  influence  should  be 
negligible  (21).  Figure  1  shows  the  viscosity  of 
the developed formulation in a non-physiological 
condition (pH of 5.0). Figure 2 shows the viscosity 
of formulation in a physiological condition (pH of 
7.2). All formulations either in non-physiological 
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of acetate buffer of pH of 5.0 which was used as 
vehicle in this case, could have contributed to the 
gelation of gellan when used beyond 0.06%, so that 
beyond this concentration gellan could not be used, 
since it form gel during the preparation process itself. 
Therefore less than this concentration was used in 
this study. In the combination systems with sodium 
alginate or sodium CMC, the concentration of gellan 
was  kept  constant  at  0.03%. A  similar  result  for 
ciprofloxacin, from gellan-based formulations with 
an increase in polymer concentration, is reported 
(20). Sodium alginate and sodium CMC were used 
as mucoadhesive agents combined with gellan at the 
concentration of 0.2, 0.4, 0.6% w/v and 0.1, 0.25, 
and  0.5%  w/v,  respectively  provided  the  defined 
fluidity of the liquid formulation.
Evaluation of the formulations
The physico-chemical properties of the prepared 
gatifloxacin formulations are shown in table 1. The 
drug  content,  clarity  and  pH  of  the  formulations 
were found to be satisfactory and the formulations 
were liquid at both room temperature and when 
refrigerated. The two main pre-requisites of 
mucoadhesive systems are viscosity and gelling 
capacity (speed and extent of gelation). Moreover, 
a mucoadhesive system should preserve its integrity 
without dissolving or eroding for a prolonged period 
of time to facilitate sustained release of the drug 
to the ocular tissues. All the formulations showed 
instantaneous gelation when contacted with the 
gelation fluids (STF). However, the nature of the 
gel which was formed depended to the polymer 
concentration. In the case of gatifloxacin formulation 
batch GG1 showed the weakest gelation, due to the 
presence of minimal amount of gellan (0.015%). 
Rheological studies
The administration of an ophthalmic formulation 
should  not  influence  the  pseudoplastic  nature  of 
the  precorneal  film,  or  the  influence  should  be 
negligible  (21).  Figure  1  shows  the  viscosity  of 
the developed formulation in a non-physiological 
condition (pH of 5.0). Figure 2 shows the viscosity 
of formulation in a physiological condition (pH of 
7.2). All formulations either in non-physiological 
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or physiological condition showed pseudoplastic 
behavior (viscosity that is high under a low shear 
rate  and  low  under  a  high  shear  rate),  which  is 
fruitful for ophthalmic use due to the fact that the 
ocular shear rate is very high ranging from 0.03 
s–1 during inter-blinking periods to 4250–28500 s–1 
during blinking (22). If the viscosity at a high shear 
rate is too high, this will result in irritation. On the 
other hand, if the viscosity is too low, it will give rise 
to increased drainage. The pseudoplastic property 
of these formulations is in favour of sustaining 
drainage  of  drugs  (from  the  conjunctival  sac  of 
the eye, without blinking difficulty in undergoing 
shear thinning). The viscosity of the formulations 
increased by increas in the concentration of the 
polymers. 
Mucoadhesive evaluation
The viscosity of mucin colloidal dispersion is the net 
result of the resistance to flow exerted by individual 
chain segment, physical chain entanglement and 
the non covalent intermolecular interaction such as 
electrostatic, hydrogen and hydrophobic bonding (23, 
24). These interactions are the identical forces involved 
in the process of mucin-polymer adhesion (25). Thus, 
force in a mucin bioadhesive system can be monitored 
by measuring viscosity. In fact, both physical and 
chemical bond energies in mucin-polymer interactions 
can be transformed into mechanical energy or work. 
This work causes changes in the shape or arrangement 
of macromolecules and is the basis of the viscosity 
changes (24).
The mucoadhesive forces of different formulations 
of gatifloxaicn mucoadhesive systems are shown in 
table 1. The mucoadhesive force (p < 0.05) increased 
significantly as the concentration of sodium alginate 
and sodium CMC increased over the range of 0.2 to 
0.6% and 0.1 to 0.5%, respectively. There was no 
significant  difference  between  the  mucoadhesive 
property  of  sodium  alginate  and  sodium  CMC                     
(p  >  0.05).  Formulation  GG5  (Containing  Gellan: 
Sodium CMC polymer ratio 0.03:0.5%) exhibited 
maximum mucoadhesive strength. The result also 
showed that the presence of sodium alginate or 
sodium CMC significantly increased the viscosity as 
well as the mucoadhesive property.
Gellan gum forms a clear gel in the presence of 
mono- or divalent cations. The electrolytes of the 
tear fluid especially Na+, Ca2+ and Mg2+ cations are 
particularly suited to initiate gelation of the polymer 
when instilled as a liquid solution into the cul-de-
sac  (26).  Once  gelled,  the  formulation  resists  the 
natural drainage process from the precorneal area. 
Residence at the site of drug absorption is prolonged 
and, subsequently, the bioavailability of the drug is 
increased (27).
Sodium  carboxymethylcellulose  (NaCMC), 
however, exhibits a mucoadhesive capacity comparable 
to that of poly(acrylic acid) (PAA) (28). It has an 
abundance of hydroxyl and ether groups along its 
length, which are responsible for mucoadhesive 
properties. Increasing the concentration of the 
sodium CMC in the formulation increased the bonds 
forming groups, thus increasing the mucoadhesicve 
force  of  the  formulations  (29).  Mucoadhesion 
behavior of alginate was due to the low surface 
tension (31.5 mN/m) of the alginate, which was lower 
than the critical surface tension of the mucin coated 
cornea (38 mN/m), resulting in good spreading and 
adhesion (30).
In vitro release
The results clearly showed that the mucoadhesive 
systems have the ability to retain gatifloxacin in its 
matrix network and that the premature drug release 
will not occur.
The effect of gellan gum concentration on drug 
release
Gatifloxacin  release  from  the  control  system  was 
fast and the system was completely depleted 
the drug within 2 hrs. Gellan gum, an anionic 
Figure1.  Rheological behavior of mucoadhesive system of 
gatifloxacin in non-physiological condition (pH, 5.0)
Figure2.  Rheological behavior of mucoadhesive system of 
gatifloxacin in physiological condition (pH, 7.2).
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physiological condition (pH of 7.2). All formulations 
either in non-physiological or physiological 
condition showed pseudo plastic behavior (viscosity 
that is high under a low shear rate and low under 
a high shear rate), which is fruitful for ophthalmic 
use due to the fact that the ocular shear rate is very 
high ranging from 0.03 s–1 during inter-blinking 
periods to 4250–28500 s–1 during blinking (22). If 
the viscosity at a high shear rate is too high, this will 
result in irritation. On the other hand, if the viscosity 
is too low, it will give rise to increased drainage. 
The pseudoplastic property of these formulations 
is in favour of sustaining drainage of drugs from 
(the conjunctival sac of the eye, without blinking 
difficulty  in  undergoing  shear  thinning).  The 
viscosity of the formulations increased by increas in 
the concentration of the polymers. 
Mucoadhesive evaluation
The viscosity of mucin colloidal dispersion is the net 
result of the resistance to flow exerted by individual 
chain segment, physical chain entanglement and 
the non covalent intermolecular interaction such as 
electrostatic, hydrogen and hydrophobic bonding (23, 
24). These interactions are the identical forces involved 
in the process of mucin-polymer adhesion (25). Thus, 
force in a mucin bioadhesive system can be monitored 
by measuring viscosity. In fact, both physical and 
chemical bond energies in mucin-polymer interactions 
can be transformed into mechanical energy or work. 
This work causes changes in the shape or arrangement 
of macromolecules and is the basis of the viscosity 
changes (24).
The mucoadhesive forces of different formulations 
of gatifloxaicn mucoadhesive systems are shown in 
Table 1. The mucoadhesive force (p < 0.05) increased 
significantly as the concentration of sodium alginate 
and sodium CMC increased over the range of 0.2 
to 0.6% and 0.1 to 0.5 %, respectively.  There was 
no significant difference between the mucoadhesive 
property of sodium alginate and sodium CMC (p > 
0.05). Formulation GG5 (Containing Gellan: Sodium 
CMC polymer ratio 0.03:0.5 %) exhibited maximum 
mucoadhesive strength. The result also showed that 
the presence of sodium alginate or sodium CMC 
significantly increased the viscosity as well as the 
mucoadhesive property.
Gellan gum forms a clear gel in the presence of 
mono- or divalent cations. The electrolytes of the 
tear fluid especially Na+, Ca2+ and Mg2+ cations are 
particularly suited to initiate gelation of the polymer 
when instilled as a liquid solution into the cul-de-
sac (26). Once gelled, the formulation resists the 
natural drainage process from the precorneal area. 
Residence at the site of drug absorption is prolonged 
and, subsequently, the bioavailability of the drug is 
increased (27).
Sodium  carboxymethylcellulose  (NaCMC), 
however, exhibits a mucoadhesive capacity comparable 
to that of poly(acrylic acid) (PAA) (28). It has an 
abundance of hydroxyl and ether groups along its 
length, which are responsible for mucoadhesive 
properties. Increasing the concentration of the 
sodium CMC in the formulation increased the bonds 
forming groups, thus increasing the mucoadhesicve 
force of the formulations (29). Mucoadhesion 
behavior of alginate was due to the low surface 
tension (31.5 mN/m) of the alginate, which was lower 
than the critical surface tension of the mucin coated 
cornea (38 mN/m), resulting in good spreading and 
adhesion (30).
In vitro release
The results clearly showed that the mucoadhesive 
systems have the ability to retain gatifloxacin in its 
matrix network and that the premature drug release 
will not occur.
The effect of gellan gum concentration on drug 
release
Gatifloxacin  release  from  the  control  system  was 
fast and the system was completely depleted 
the drug within 2 hrs. Gellan gum, an anionic 
polysaccharide, when incorporated as a part (0.015 
Figure1.  Rheological behavior of mucoadhesive system of 
gatifloxacin in non-physiological condition (pH, 5.0)
Figure2.  Rheological behavior of mucoadhesive system of 
gatifloxacin in physiological condition (pH, 7.2).
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physiological condition (pH of 7.2). All formulations 
either in non-physiological or physiological 
condition showed pseudo plastic behavior (viscosity 
that is high under a low shear rate and low under 
a high shear rate), which is fruitful for ophthalmic 
use due to the fact that the ocular shear rate is very 
high ranging from 0.03 s–1 during inter-blinking 
periods to 4250–28500 s–1 during blinking (22). If 
the viscosity at a high shear rate is too high, this will 
result in irritation. On the other hand, if the viscosity 
is too low, it will give rise to increased drainage. 
The pseudoplastic property of these formulations 
is in favour of sustaining drainage of drugs from 
(the conjunctival sac of the eye, without blinking 
difficulty  in  undergoing  shear  thinning).  The 
viscosity of the formulations increased by increas in 
the concentration of the polymers. 
Mucoadhesive evaluation
The viscosity of mucin colloidal dispersion is the net 
result of the resistance to flow exerted by individual 
chain segment, physical chain entanglement and 
the non covalent intermolecular interaction such as 
electrostatic, hydrogen and hydrophobic bonding (23, 
24). These interactions are the identical forces involved 
in the process of mucin-polymer adhesion (25). Thus, 
force in a mucin bioadhesive system can be monitored 
by measuring viscosity. In fact, both physical and 
chemical bond energies in mucin-polymer interactions 
can be transformed into mechanical energy or work. 
This work causes changes in the shape or arrangement 
of macromolecules and is the basis of the viscosity 
changes (24).
The mucoadhesive forces of different formulations 
of gatifloxaicn mucoadhesive systems are shown in 
Table 1. The mucoadhesive force (p < 0.05) increased 
significantly as the concentration of sodium alginate 
and sodium CMC increased over the range of 0.2 
to 0.6% and 0.1 to 0.5 %, respectively.  There was 
no significant difference between the mucoadhesive 
property of sodium alginate and sodium CMC (p > 
0.05). Formulation GG5 (Containing Gellan: Sodium 
CMC polymer ratio 0.03:0.5 %) exhibited maximum 
mucoadhesive strength. The result also showed that 
the presence of sodium alginate or sodium CMC 
significantly increased the viscosity as well as the 
mucoadhesive property.
Gellan gum forms a clear gel in the presence of 
mono- or divalent cations. The electrolytes of the 
tear fluid especially Na+, Ca2+ and Mg2+ cations are 
particularly suited to initiate gelation of the polymer 
when instilled as a liquid solution into the cul-de-
sac (26). Once gelled, the formulation resists the 
natural drainage process from the precorneal area. 
Residence at the site of drug absorption is prolonged 
and, subsequently, the bioavailability of the drug is 
increased (27).
Sodium  carboxymethylcellulose  (NaCMC), 
however, exhibits a mucoadhesive capacity comparable 
to that of poly(acrylic acid) (PAA) (28). It has an 
abundance of hydroxyl and ether groups along its 
length, which are responsible for mucoadhesive 
properties. Increasing the concentration of the 
sodium CMC in the formulation increased the bonds 
forming groups, thus increasing the mucoadhesicve 
force of the formulations (29). Mucoadhesion 
behavior of alginate was due to the low surface 
tension (31.5 mN/m) of the alginate, which was lower 
than the critical surface tension of the mucin coated 
cornea (38 mN/m), resulting in good spreading and 
adhesion (30).
In vitro release
The results clearly showed that the mucoadhesive 
systems have the ability to retain gatifloxacin in its 
matrix network and that the premature drug release 
will not occur.
The effect of gellan gum concentration on drug 
release
Gatifloxacin  release  from  the  control  system  was 
fast and the system was completely depleted 
the drug within 2 hrs. Gellan gum, an anionic 
polysaccharide, when incorporated as a part (0.015 
Figure1.  Rheological behavior of mucoadhesive system of 
gatifloxacin in non-physiological condition (pH, 5.0)
Figure2.  Rheological behavior of mucoadhesive system of 
gatifloxacin in physiological condition (pH, 7.2).
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polysaccharide, when incorporated as a part 
(0.015%  to  0.06%  w/v),  controlled  the  release 
rate  of  the  drug  significantly  (p<0.001)  (Fig3). 
Gellan gum undergoes gelation in the presence 
of cations, via a chemical bonding between the 
divalent cations and two COO− groups of guluronic 
acid molecules in gellan chains (31). It is evident 
from the figure 3 that even at lower concentrations 
of gellan gum; the drug release was sustained for 
an extended period. Drug release seemed to slow 
down with an increase in gellan concentration. The 
release was significantly (p<0.001) slowed when 
the polymer concentration increased from 0.03% 
to 0.045% and 0.06%, while there was not much 
difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5).  The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1%  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium  CMC.  Sodium  alginate,  incorporated  at 
0.2%  to  0.6%  w/v  significantly  affected  the  drug 
release (p<0.001), thus indicating the additive effect 
of the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The correlation coefficient (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive 
system  predominately  followed  Higuchi’s  square 
root of time kinetics, as the values for Q vs. t1/2 
(0.971-0.995)  were  always  higher  than  those  for 
Q vs. t  (0.649-0.957) and log (100-Q) vs. t (0.85-
Figure3. Effects of gellan gum concentration on the drug release 
Values are reported as mean ± SD (n = 3).
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% to 0.06 % w/v), controlled the release rate of the 
drug significantly (p < 0.001) (Figure 3). Gellan 
gum undergoes gelation in the presence of cations, 
via a chemical bonding between the divalent cations 
and two COO− groups of guluronic acid molecules 
in gellan chains (31). It is evident from the Figure 
3 that even at lower concentrations of gellan gum; the 
drug release was sustained for an extended period. 
Drug release seemed to slow down with an increase 
in gellan concentration. The release was significantly 
(p < 0.001) slowed when the polymer concentration 
increased from 0.03% to 0.045 and 0.06, while there 
was not much difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5). The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium CMC. Sodium alginate, incorporated at 0.2 
to 0.6% w/v significantly affected the drug release 
(p < 0.001), thus indicating the additive effect of 
the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The  correlation  coefficient  (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive system 
predominately  followed  Higuchi’s  square  root  of 
time kinetics, as the values for Q vs. t1/2 (0.971–
0.995) were always higher than those for Q vs. t 
(0.649–0.957)  and  log  (100–Q)  vs.  t  (0.85–0.968). 
Release exponent, n, was >0.5 but <1, for all the batches 
indicating an anomalous or non-Fickian release and 
Figure3. Effects of gellan gum concentration on the drug release 
Values are reported as mean ± SD (n = 3).
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% to 0.06 % w/v), controlled the release rate of the 
drug significantly (p < 0.001) (Figure 3). Gellan 
gum undergoes gelation in the presence of cations, 
via a chemical bonding between the divalent cations 
and two COO− groups of guluronic acid molecules 
in gellan chains (31). It is evident from the Figure 
3 that even at lower concentrations of gellan gum; the 
drug release was sustained for an extended period. 
Drug release seemed to slow down with an increase 
in gellan concentration. The release was significantly 
(p < 0.001) slowed when the polymer concentration 
increased from 0.03% to 0.045 and 0.06, while there 
was not much difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5). The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium CMC. Sodium alginate, incorporated at 0.2 
to 0.6% w/v significantly affected the drug release 
(p < 0.001), thus indicating the additive effect of 
the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The  correlation  coefficient  (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive system 
predominately  followed  Higuchi’s  square  root  of 
time kinetics, as the values for Q vs. t1/2 (0.971–
0.995) were always higher than those for Q vs. t 
(0.649–0.957)  and  log  (100–Q)  vs.  t  (0.85–0.968). 
Release exponent, n, was >0.5 but <1, for all the batches 
indicating an anomalous or non-Fickian release and 
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% to 0.06 % w/v), controlled the release rate of the 
drug significantly (p < 0.001) (Figure 3). Gellan 
gum undergoes gelation in the presence of cations, 
via a chemical bonding between the divalent cations 
and two COO− groups of guluronic acid molecules 
in gellan chains (31). It is evident from the Figure 
3 that even at lower concentrations of gellan gum; the 
drug release was sustained for an extended period. 
Drug release seemed to slow down with an increase 
in gellan concentration. The release was significantly 
(p < 0.001) slowed when the polymer concentration 
increased from 0.03% to 0.045 and 0.06, while there 
was not much difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5). The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium CMC. Sodium alginate, incorporated at 0.2 
to 0.6% w/v significantly affected the drug release 
(p < 0.001), thus indicating the additive effect of 
the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The  correlation  coefficient  (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive system 
predominately  followed  Higuchi’s  square  root  of 
time kinetics, as the values for Q vs. t1/2 (0.971–
0.995) were always higher than those for Q vs. t 
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polysaccharide, when incorporated as a part 
(0.015%  to  0.06%  w/v),  controlled  the  release 
rate  of  the  drug  significantly  (p<0.001)  (Fig3). 
Gellan gum undergoes gelation in the presence 
of cations, via a chemical bonding between the 
divalent cations and two COO− groups of guluronic 
acid molecules in gellan chains (31). It is evident 
from the figure 3 that even at lower concentrations 
of gellan gum; the drug release was sustained for 
an extended period. Drug release seemed to slow 
down with an increase in gellan concentration. The 
release was significantly (p<0.001) slowed when 
the polymer concentration increased from 0.03% 
to 0.045% and 0.06%, while there was not much 
difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5).  The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1%  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium  CMC.  Sodium  alginate,  incorporated  at 
0.2%  to  0.6%  w/v  significantly  affected  the  drug 
release (p<0.001), thus indicating the additive effect 
of the formed calcium alginate on gel formation and 
consequently on drug release.
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The correlation coefficient (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive 
system  predominately  followed  Higuchi’s  square 
root of time kinetics, as the values for Q vs. t1/2 
(0.971-0.995)  were  always  higher  than  those  for 
Q vs. t  (0.649-0.957) and log (100-Q) vs. t (0.85-
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% to 0.06 % w/v), controlled the release rate of the 
drug significantly (p < 0.001) (Figure 3). Gellan 
gum undergoes gelation in the presence of cations, 
via a chemical bonding between the divalent cations 
and two COO− groups of guluronic acid molecules 
in gellan chains (31). It is evident from the Figure 
3 that even at lower concentrations of gellan gum; the 
drug release was sustained for an extended period. 
Drug release seemed to slow down with an increase 
in gellan concentration. The release was significantly 
(p < 0.001) slowed when the polymer concentration 
increased from 0.03% to 0.045 and 0.06, while there 
was not much difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5). The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
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natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium CMC. Sodium alginate, incorporated at 0.2 
to 0.6% w/v significantly affected the drug release 
(p < 0.001), thus indicating the additive effect of 
the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The  correlation  coefficient  (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive system 
predominately  followed  Higuchi’s  square  root  of 
time kinetics, as the values for Q vs. t1/2 (0.971–
0.995) were always higher than those for Q vs. t 
(0.649–0.957)  and  log  (100–Q)  vs.  t  (0.85–0.968). 
Release exponent, n, was >0.5 but <1, for all the batches 
indicating an anomalous or non-Fickian release and 
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% to 0.06 % w/v), controlled the release rate of the 
drug significantly (p < 0.001) (Figure 3). Gellan 
gum undergoes gelation in the presence of cations, 
via a chemical bonding between the divalent cations 
and two COO− groups of guluronic acid molecules 
in gellan chains (31). It is evident from the Figure 
3 that even at lower concentrations of gellan gum; the 
drug release was sustained for an extended period. 
Drug release seemed to slow down with an increase 
in gellan concentration. The release was significantly 
(p < 0.001) slowed when the polymer concentration 
increased from 0.03% to 0.045 and 0.06, while there 
was not much difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5). The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium CMC. Sodium alginate, incorporated at 0.2 
to 0.6% w/v significantly affected the drug release 
(p < 0.001), thus indicating the additive effect of 
the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The  correlation  coefficient  (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive system 
predominately  followed  Higuchi’s  square  root  of 
time kinetics, as the values for Q vs. t1/2 (0.971–
0.995) were always higher than those for Q vs. t 
(0.649–0.957)  and  log  (100–Q)  vs.  t  (0.85–0.968). 
Release exponent, n, was >0.5 but <1, for all the batches 
indicating an anomalous or non-Fickian release and 
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% to 0.06 % w/v), controlled the release rate of the 
drug significantly (p < 0.001) (Figure 3). Gellan 
gum undergoes gelation in the presence of cations, 
via a chemical bonding between the divalent cations 
and two COO− groups of guluronic acid molecules 
in gellan chains (31). It is evident from the Figure 
3 that even at lower concentrations of gellan gum; the 
drug release was sustained for an extended period. 
Drug release seemed to slow down with an increase 
in gellan concentration. The release was significantly 
(p < 0.001) slowed when the polymer concentration 
increased from 0.03% to 0.045 and 0.06, while there 
was not much difference between the release patterns. 
The effect of sodium carboxymethylcellulose 
concentration on drug release
Figure 4 shows the effect of sodium carboxymethyl 
cellulose on the drug release. Gellan at a 
concentration  of  0.03%  w/v  was  present  in  the 
formulation containing varying proportion of 
sodium  carboxymethyl  cellulose  (GG3-GG5). The 
release of drug depends not only on the nature of 
the matrix, but also upon the polymer concentration. 
This may be due to structural reorganization of the 
hydrophilic polymer, sodium CMC. When sodium 
CMC is exposed to an aqueous medium, it undergoes 
rapid hydration and chain relaxation to form a 
viscose gelatinous layer (gel layer). Comparison of 
the release profile of GG2 (containing only gellan) 
with those of GG3-GG5 indicate the burst effect 
was considerably reduced. Sodium carboxymethyl 
cellulose,  was  incorporated  at  0.1  to  0.5%  w/v 
affected the drug release significantly (p < 0.001).
The effect of sodium alginate concentration on drug 
release
Figure 5 shows the effect of sodium algiante on the 
drug release. Alginic acid is insoluble in water, but 
sodium alginate produces clear gels. Alginate is a 
natural block copolymer containing two types of 
monomers:  beta-D  mannuronic  acid  and  alpha-L- 
guluronic acid. Alginates with a high guluronic acid 
content improve the gelling properties and reduce 
the total polymer to be introduced into the eye. The 
alginate forms 3-dimensional ionotropic hydrogel 
matrics, generally by the preferential interaction 
of calcium ions with the ‘G’ moieties resulting in 
the formation of a inhomogeneous gel (32). Gellan 
at a concentration of 0.03% w/v was present in the 
formulation containing varying proportion of sodium 
alginate (GM1-GM3). Results showed that the release 
retarding effect of sodium alginate was greater than 
sodium CMC. Sodium alginate, incorporated at 0.2 
to 0.6% w/v significantly affected the drug release 
(p < 0.001), thus indicating the additive effect of 
the formed calcium alginate on gel formation and 
consequently on drug release.
Kinetic Analysis
The  correlation  coefficient  (r2) values for various 
release  models  viz.,  zero-order,  first-order,  and 
Higuchi models, were found. The r2 values suggest 
that the drug release from the mucoadhesive system 
predominately  followed  Higuchi’s  square  root  of 
time kinetics, as the values for Q vs. t1/2 (0.971–
0.995) were always higher than those for Q vs. t 
(0.649–0.957)  and  log  (100–Q)  vs.  t  (0.85–0.968). 
Release exponent, n, was >0.5 but <1, for all the batches 
indicating an anomalous or non-Fickian release and 
Figure3. Effects of gellan gum concentration on the drug release 
Values are reported as mean ± SD (n = 3).
Figure 4. E f f e c t s   o f   s o d i u m   C M C   c o n c e n t r a t i o n   o n   t h e   d r u g   r e l e a s e                                                                                     
Values are reported as mean ± SD (n = 3)
Figure 5. Effects of sodium alginate concentration on the drug release 
Values are reported as mean ± SD (n = 3)
Kesavan et al / DARU 2010 18 (4) ? -? 3244 ?
0.968). Release exponent, n, was >0.5 but <1, for all 
the batches indicating an anomalous or non-Fickian 
release and suggesting a coupled erosion– diffusion 
mechanism for the tested gatifloxacin mucoadhesive 
system.
Antimicrobial efficacy studies
Determination of minimum inhibitory concentration 
(MIC)
MIC  determination  was  carried  out  using  serial 
dilution method. In GG5 formulation and pure drug 
sample  the  MIC  concentration  was  found  to  be 
0.15 and 0.075 μg/ml against S.aureus and E.coli, 
respectively.  It  showed  that  gatifloxacin  retain 
its  antimicrobial  efficacy  when  formulated  as  a 
mucoadhesive system.
In vitro antibacterial activity
Figure 6 shows the in vitro antibacterial activity of 
free GTN and GTN mucoadhesive system against E. 
coli and S.aureus. A significant decrease in OD600 
value was observed in comparison with control 
(p<0.001). In the control set the OD600 value of 
E.coli and S.aureus increased with time. 
In the control set the number of viable organisms 
increased with time. The control group was 
treated not any antimicrobial agent. Thus under 
favorable  conditions  (temperature  and  nutrient) 
the test organisms exhibited a significant growth. 
The growth of organisms was reduced or inhibited 
in the presence of either the solution form or the 
formulation as it was evident from the growth 
curve.  Although  no  significant  difference  was 
Figure 8. DSC endotherm of pure Gatifloxacin, polymers and freeze dried formulations.
A – Drug; B – freeze dried formulation (GG5); C – freeze dried formulation (GM3); D – Gellan gum; E – Sodium CMC; F - Sodium alginate
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of either the solution form or the formulation as it 
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significant  difference  was  observed  between  the 
antimicrobial activity of the drug and the formulation 
(p > 0.001), a marginal increase of the viable count 
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0.968). Release exponent, n, was >0.5 but <1, for all 
the batches indicating an anomalous or non-Fickian 
release and suggesting a coupled erosion– diffusion 
mechanism for the tested gatifloxacin mucoadhesive 
system.
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mucoadhesive system.
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Figure 6 shows the in vitro antibacterial activity of 
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value was observed in comparison with control 
(p<0.001). In the control set the OD600 value of 
E.coli and S.aureus increased with time. 
In the control set the number of viable organisms 
increased with time. The control group was 
treated not any antimicrobial agent. Thus under 
favorable  conditions  (temperature  and  nutrient) 
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formulation as it was evident from the growth 
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observed between the antimicrobial activity of the 
drug and the formulation (p>0.001), a marginal 
increase of the viable count was observed in 
sample tubes containing drug solution after ~4 hrs, 
while no increase in the viable count was observed 
during the 8 hrs incubation with formulation. 
These results showed the sustained release 
characteristics  of  gatifloxacin  mucoadhesive 
system, that released GTN inhibits bacterial 
growth for a longer period.
IR Study
IR  spectrums  were  recorded  for  pure  gatifloxacin, 
polymers and freeze dried formulations (Fig 7). In 
both cases it was observed that the characteristic 
bands did not shift appreciably, suggesting the 
lack of any interaction between the drug and 
excipients. 
DSC Study
DSC  thermograms  were  recorded  for  pure 
gatifloxacin, polymers and freeze dried formulations 
(Fig  8).  In  both  cases  it  was  observed  that  the 
characteristic endotherm (corresponding to melt of the 
drugs) did not shift appreciably, suggesting the lack of 
any interaction between the drug and excipients. 
CONCLUSION
Gatifloxacin  was  successfully  formulated  as  a 
mucoadhesive system using gellan combination 
with sodium carboxymethyl cellulose and sodium 
alginate. In vitro antibacterial activity of GG5 was 
evaluated against S. aureus and E. coli, in vitro. The 
formulated systems provided sustained release of 
the drug over a 12 hrs period in vitro. A Significant 
reduction in total bacterial count between drug 
solution (control) and mucoadhesive system was 
noted  with  both  two  organisms.  However,  GG5 
effectively inhibited the growth of bacteria due to 
the sustained release characteristics of hydrogels. 
The developed formulation is a viable alternative 
to conventional eye drops for its ability to enhance 
bioavailability through its longer precorneal 
residence time and its ability to sustain the release 
of the drug. Also easy and decreased frequency of 
administration results in better patient compliance.         
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